Shanghai BDgene’s BD111 Gene Therapy Advances to Phase II Clinical Trials
Gene therapy specialist Shanghai BDgene Technology Co., Ltd has advanced its BD111 pipeline candidate into...
Gene therapy specialist Shanghai BDgene Technology Co., Ltd has advanced its BD111 pipeline candidate into...
Shanghai BDgene Technology Co., Ltd, a leading gene therapy specialist based in China, has entered...
Shanghai BDgene Technology Co., Ltd., a China-based specialist in gene therapy, has entered into a...
Shanghai BDgene Technology Co., Ltd, a specialist in gene therapy, has received clinical trial approval...
Shanghai BDgene Technology Co., Ltd, a specialist in gene therapy, has announced that its drug...
Gene therapy specialist Shanghai BDgene Technology Co., Ltd has announced the conclusion of three clinical...
Gene therapy specialist Shanghai BDgene Technology Co., Ltd has announced receiving approval from the US...
Gene therapy specialist Shanghai BDgene Technology Co., Ltd has successfully raised over RMB 200 million...
Shanghai BDgene Technology Co., Ltd has announced that it has received tacit clinical trial approval...
Shanghai BDgene Technology Co., Ltd has announced that a clinical trial filing for its BD111,...
Shanghai BDgene Technology Co., Ltd has completed efficacy and preliminary safety studies for BD111, its...